Endpoint definition
↥| Name | E4_AMYLNAS |
|---|---|
| Long name | Amyloidosis, other/unspecified |
| Hospital Discharge registry | ICD-10: E859, ICD-8: 27699 |
| Cause of Death registry | ICD-10: E859, ICD-8: 27699 |
| Level in the ICD-hierarchy | 4 |
| First defined in version | DF2 |
Amyloidosis, other/unspecified
amyloidosis: A disorder characterized by the localized or diffuse accumulation of amyloid protein in various anatomic sites. It may be primary, due to clonal plasma cell proliferations; secondary, due to long standing infections, chronic inflammatory disorders, or malignancies; or familial. It may affect the nerves, skin, tongue, joints, heart, liver, spleen, kidneys and adrenal glands.
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 180 | 88 | 92 |
| Unadjusted prevalence (%) | 0.08 | 0.07 | 0.10 |
| Mean age at first event (years) | 61.15 | 58.55 | 63.63 |
| Case fatality at 5-years (%) | 20.56 | 20.45 | 20.65 |
Longitudinal metrics
| All | Female | Male | |
|---|---|---|---|
| Median nb. of events per indiv. | 3.0 | 4.5 | 3.0 |
| Recurrence at 6 months (%) | 60.56 | 65.91 | 55.43 |
Survival analyses between endpoints
↥Plot
before Amyloidosis, other/unspecified
after Amyloidosis, other/unspecified
Loading survival analyses plot…
Table
Loading survival analyses table…